U.S. Code · Título 42
Interagency Breast Cancer and Environmental Research Coordinating Committee
42 U.S.C. § 285a–12
Office of the Law Revision Counsel · release 119-142
Se muestra el texto operativo de la sección. Las notas estatutarias y el historial de enmiendas están en la fuente oficial.
Interagency Breast Cancer and Environmental Research Coordinating Committee
Establishment
Not later than 6 months after October 8, 2008, the Secretary shall establish a committee, to be known as the Interagency Breast Cancer and Environmental Research Coordinating Committee (in this section referred to as the “Committee”).
Duties
The Committee shall—
develop a comprehensive strategy and advise the National Institutes of Health and other Federal agencies in the solicitation of proposals for collaborative, multidisciplinary research, including proposals to evaluate environmental and genomic factors that may be related to the etiology of breast cancer that would—
not later than 2 years after the date of the establishment of the Committee, make recommendations to the Secretary—
Rule of construction
For the purposes of the Committee, when focusing on research to evaluate environmental and genomic factors that may be related to the etiology of breast cancer, nothing in this section shall be construed to restrict the Secretary from including other forms of cancer, as appropriate, when doing so may advance research in breast cancer or advance research in other forms of cancer.
Membership
In general
The Committee shall be composed of the following voting members:
Not more than 7 voting Federal representatives as follows:
Additional members
The Committee shall include additional voting members appointed by the Secretary as follows:
6 members shall be appointed from among scientists, physicians, and other health professionals, who—
Nonvoting members
The Committee shall include such nonvoting members as the Secretary determines to be appropriate.
Chairperson
The voting members of the Committee shall select a chairperson from among such members. The selection of a chairperson shall be subject to the approval of the Director of NIH.
Meetings
The Committee shall meet at the call of the chairperson of the Committee or upon the request of the Director of NIH, but in no case less often than once each year.
Review
The Secretary shall review the necessity of the Committee in calendar year 2011 and, thereafter, at least once every 2 years.
(July 1, 1944, ch. 373, title IV, § 417F, as added Pub. L. 110–354, § 2(a), Oct. 8, 2008, 122 Stat. 3984.)